Circulation. 1998;97:1325-1335
(Circulation. 1998;97:1325-1335.)
© 1998 American Heart Association, Inc.
ACC/AHA Practice Guidelines |
ACC/AHA Guidelines for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices: Executive Summary
A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Pacemaker Implantation)
Gabriel Gregoratos, MD, FACC, Chair;
Melvin D. Cheitlin, MD, FACC;
Alicia Conill, MD, FACP1;
Andrew E. Epstein, MD, FACC;
Christopher Fellows, MD, FACC;
T. Bruce Ferguson, Jr, MD, FACC2;
Roger A. Freedman, MD, FACC;
Mark A. Hlatky, MD, FACC;
Gerald V. Naccarelli, MD, FACC;
Sanjeev Saksena, MD, MBBS, FACC3;
Robert C. Schlant, MD, FACC;
; Michael J. Silka, MD, FACC
Key Words: AHA Medical/Scientific Statements • pacemakers • pacing • arrhythmia
Executive Summary
I. Introduction
The publication of major studies dealing with the
natural history of bradyarrhythmias and
tachyarrhythmias and major advances in the technology
of pacemakers and implantable cardioverter-defibrillators (ICDs) has
mandated this revision of the 1991 ACC/AHA Guidelines for Implantation
of Pacemakers and Antiarrhythmia Devices.
This executive summary appears in the April 7, 1998 issue of
Circulation. The full text of the guidelines, including the
ACC/AHA Class I, II, and III recommendations, is published in the April
1998 issue of the Journal of the American College of
Cardiology. Reprints of both the executive summary
and the full text are available from both organizations.
Following extensive review of the medical literature and related
documents previously published by the American College of
Cardiology, the American Heart Association, and the
North American Society for Pacing and Electrophysiology, the writing
committee developed recommendations that are evidence based whenever
possible.
Evidence supporting current recommendations is ranked as level A if the
data were derived from multiple randomized clinical trials
involving a large number of individuals. Evidence was ranked as level B
when data were derived from a limited number of trials involving
comparatively small numbers of patients or from well-designed data
analysis of nonrandomized studies or
observational data registries. Evidence was ranked as level
C when consensus of expert opinion was the primary source of
recommendation. The committee emphasizes that for certain conditions
for which no other therapies are available, the indications for device
therapies are based on years of clinical experience as well as expert
consensus and . . . [Full Text of this Article]
4
-->
This article has been cited by other articles:
|
|
|
|
 
K. Etsadashvili, F. Hintringer, M. Stuhlinger, W. Dichtl, K. Spuller, H. Antretter, H. Hangler, O. Pachinger, F. X. Roithinger, and T. Berger
Long-term results of high vs. normal impedance ventricular leads on actual (Real-Life) pacemaker generator longevity
Europace,
February 1, 2009;
11(2):
200 - 205.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. E. Albertsen, J. C. Nielsen, S. H. Poulsen, P. T. Mortensen, A. K. Pedersen, P. S. Hansen, H. K. Jensen, and H. Egeblad
Biventricular pacing preserves left ventricular performance in patients with high-grade atrio-ventricular block: a randomized comparison with DDD(R) pacing in 50 consecutive patients
Europace,
March 1, 2008;
10(3):
314 - 320.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Nagahara, T. Nakata, A. Hashimoto, T. Wakabayashi, M. Kyuma, R. Noda, S. Shimoshige, K. Uno, K. Tsuchihashi, and K. Shimamoto
Predicting the Need for an Implantable Cardioverter Defibrillator Using Cardiac Metaiodobenzylguanidine Activity Together with Plasma Natriuretic Peptide Concentration or Left Ventricular Function
J. Nucl. Med.,
February 1, 2008;
49(2):
225 - 233.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Agard, R. Lofmark, N. Edvardsson, and I. Ekman
Views of patients with heart failure about their role in the decision to start implantable cardioverter defibrillator treatment: prescription rather than participation
J. Med. Ethics,
September 1, 2007;
33(9):
514 - 518.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. K. Khan, K. M. Goode, J. G.F. Cleland, A. S. Rigby, N. Freemantle, J. Eastaugh, A. L. Clark, R. de Silva, M. J. Calvert, K. Swedberg, et al.
Prevalence of ECG abnormalities in an international survey of patients with suspected or confirmed heart failure at death or discharge
Eur J Heart Fail,
May 1, 2007;
9(5):
491 - 501.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. L. Stoller
Ophthalmic Surgery and the Implantable Cardioverter Defibrillator
Arch Ophthalmol,
January 1, 2006;
124(1):
123 - 125.
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Gabor, G. Prenner, A. Wasler, M. Schweiger, K. H. Tscheliessnigg, and F. M. Smolle-Juttner
A simplified technique for implantation of left ventricular epicardial leads for biventricular resynchronisation using video-assisted thoracoscopy (VATS)
Eur. J. Cardiothorac. Surg.,
December 1, 2005;
28(6):
797 - 800.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Capucci, M. Santini, L. Padeletti, M. Gulizia, G. Botto, G. Boriani, R. Ricci, S. Favale, F. Zolezzi, N. Di Belardino, et al.
Monitored Atrial Fibrillation Duration Predicts Arterial Embolic Events in Patients Suffering From Bradycardia and Atrial Fibrillation Implanted With Antitachycardia Pacemakers
J. Am. Coll. Cardiol.,
November 15, 2005;
46(10):
1913 - 1920.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. T. Berger
The Ethics of Deactivating Implanted Cardioverter Defibrillators
Ann Intern Med,
April 19, 2005;
142(8):
631 - 634.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Bansch, F. Steffgen, G. Gronefeld, C. Wolpert, D. Bocker, R.-U. Mletzko, W. Schols, K. Seidl, M. Piel, F. Ouyang, et al.
The 1+1 Trial: A Prospective Trial of a Dual- Versus a Single-Chamber Implantable Defibrillator in Patients With Slow Ventricular Tachycardias
Circulation,
August 31, 2004;
110(9):
1022 - 1029.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Voigt, R. Ezzeddine, W. Barrington, O. Obiaha-Ngwu, L. I. Ganz, B. London, and S. Saba
Utilization of implantable cardioverter-defibrillators in survivors of cardiac arrest in the United States from 1996 to 2001
J. Am. Coll. Cardiol.,
August 18, 2004;
44(4):
855 - 858.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Chen-Scarabelli and T. M Scarabelli
Neurocardiogenic syncope
BMJ,
August 7, 2004;
329(7461):
336 - 341.
[Full Text]
[PDF]
|
|
|
|
|
|
|
D.J. Farwell, N. Freemantle, and A.N. Sulke
Use of implantable loop recorders in the diagnosis and management of syncope
Eur. Heart J.,
July 2, 2004;
25(14):
1257 - 1263.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. Whang, M. A. Mittleman, D. Q. Rich, P. J. Wang, J. N. Ruskin, G. H. Tofler, J. E. Muller, C. M. Albert, and for the TOVA Investigators
Heart Failure and the Risk of Shocks in Patients With Implantable Cardioverter Defibrillators: Results From the Triggers Of Ventricular Arrhythmias (TOVA) Study
Circulation,
March 23, 2004;
109(11):
1386 - 1391.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. A. Lee, R. Weachter, S. Pollak, M. S. Kremers, A. M. Naik, R. Silverman, J. Tuzi, W. Wang, L. J. Johnson, D. E. Euler, et al.
The effect of atrial pacing therapies on atrial tachyarrhythmia burden and frequency: Results of a randomized trial in patients with bradycardia and atrial tachyarrhythmias
J. Am. Coll. Cardiol.,
June 4, 2003;
41(11):
1926 - 1932.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. B. Young, W. T. Abraham, A. L. Smith, A. R. Leon, R. Lieberman, B. Wilkoff, R. C. Canby, J. S. Schroeder, L. B. Liem, S. Hall, et al.
Combined Cardiac Resynchronization and Implantable Cardioversion Defibrillation in Advanced Chronic Heart Failure: The MIRACLE ICD Trial
JAMA,
May 28, 2003;
289(20):
2685 - 2694.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. A. Ezekowitz, P. W. Armstrong, and F. A. McAlister
Implantable Cardioverter Defibrillators in Primary and Secondary Prevention: A Systematic Review of Randomized, Controlled Trials
Ann Intern Med,
March 18, 2003;
138(6):
445 - 452.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. A. Ellenbogen, M. A. Wood, R. K. Shepard, H. F. Clemo, T. Vaughn, K. Holloman, M. Dow, J. Leffler, A. Abeyratne, and D. Verness
Detection and management of animplantable cardioverter defibrillator lead failure: Incidence and clinical implications
J. Am. Coll. Cardiol.,
January 1, 2003;
41(1):
73 - 80.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. H. Maisel and W. G. Stevenson
Syncope -- Getting to the Heart of the Matter
N. Engl. J. Med.,
September 19, 2002;
347(12):
931 - 933.
[Full Text]
[PDF]
|
|
|
|
|
|
|
C Stellbrink, A.-M Sinha, B Diem, A Auricchio, S Boccanelli, J Brugada, H Klein, J Morgan, L Padeletti, E Aliot, et al.
Implantable card ioverter-defibrillators with or without cardiac resynchronization therapy -- multiple therapy in a single device: a review with special reference to the PACIVIAN study
Eur. Heart J. Suppl.,
April 1, 2002;
4(suppl_D):
D88 - D94.
[Abstract]
[PDF]
|
|
|
|
|
|
|
G Baron-Esquivias, A Pedrote, A Cayuela, J.I Valle, J.M Fernandez, E Arana, M Fernandez, F Morales, J Burgos, and A Martinez-Rubio
Long-term outcome of patients with asystole induced by head-up tilt test
Eur. Heart J.,
March 2, 2002;
23(6):
483 - 489.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Viskin, A. Halkin, and J. E. Olgin
Treatable causes of sudden death: not really "treatable" or not really the cause?
J. Am. Coll. Cardiol.,
November 15, 2001;
38(6):
1725 - 1727.
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Disertori, L. Padeletti, M. Santini, P. Dini, M. Gasparini, G. Inama, M. Botto, G. Boriani, A. Capucci, R. Ricci, et al.
Antitachycardia pacing therapies to terminate atrial tachyarrhythmias: the AT500 Italian Registry
Eur. Heart J. Suppl.,
November 1, 2001;
3(suppl_P):
P16 - P24.
[Abstract]
[PDF]
|
|
|
|
|
|
|
D. V. Exner, G. J. Klein, and E. N. Prystowsky
Primary Prevention of Sudden Death With Implantable Defibrillator Therapy in Patients With Cardiac Disease: Can We Afford to Do It? (Can We Afford Not To?)
Circulation,
September 25, 2001;
104(13):
1564 - 1570.
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Bryce, S. R. Spielman, A. M. Greenspan, and M. N. Kotler
Evolving Indications for Permanent Pacemakers
Ann Intern Med,
June 19, 2001;
134(12):
1130 - 1141.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D.A. Wood, K.F. Fox, and S.R. Gibbs
Rapid cardiology--for chest pain, breathlessness and palpitations
QJM,
April 1, 2001;
94(4):
177 - 178.
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. H. Gollob and J. J. Seger
Current Status of the Implantable Cardioverter-Defibrillator
Chest,
April 1, 2001;
119(4):
1210 - 1221.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Nitta, M. Mitsuno, C. K. Rokkas, R. Lee, R. B. Schuessler, and J. P. Boineau
Cryoablation of ventricular tachycardia guided by return cycle mapping after entrainment
J. Thorac. Cardiovasc. Surg.,
February 1, 2001;
121(2):
0249 - 258.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Glatter and L. B. Liem
Implantable Cardioverter Defibrillator: Current Progress and Management
Seminars in Cardiothoracic and Vascular Anesthesia,
September 1, 2000;
4(3):
162 - 179.
[Abstract]
[PDF]
|
|
|
|
|
|
|
S. C. HAMMILL and R. D. HUBMAYR
The Rapidly Changing Management of Cardiac Arrhythmias
Am. J. Respir. Crit. Care Med.,
April 1, 2000;
161(4):
1070 - 1073.
[Full Text]
|
|
|
|
|
|
|
A S KURBAAN and R SUTTON
Pacing for vasovagal syncope
Heart,
December 1, 1999;
82(6):
649 - 650.
[Full Text]
|
|
|
|
|
|
|
M. Vassolo and G.A. Lamas
Dual-chamber vs ventricular pacing in the elderly: quality of life and clinical outcomes
Eur. Heart J.,
November 2, 1999;
20(22):
1607 - 1608.
[PDF]
|
|
|
|
|
|
|
U. Bauersfeld, B. Nowak, L. Molinari, T. Malm, C. Kampmann, M. H. Schonbeck, and H. Schuller
Low-energy epicardial pacing in children: the benefit of autocapture
Ann. Thorac. Surg.,
October 1, 1999;
68(4):
1380 - 1383.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Guidelines for Pacemakers and Defibrillators Updated
Journal Watch (General),
April 17, 1998;
1998(417):
2 - 2.
[Full Text]
|
|
|
